Catapano, A. L., Pirillo, A., & Norata, G. D. (2017). Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives. Vasc Health Risk Manag.
Chicago Stili AlıntıCatapano, Alberico Luigi, Angela Pirillo, ve Giuseppe Danilo Norata. "Anti-PCSK9 Antibodies for the Treatment of Heterozygous Familial Hypercholesterolemia: Patient Selection and Perspectives." Vasc Health Risk Manag 2017.
MLA AlıntıCatapano, Alberico Luigi, Angela Pirillo, ve Giuseppe Danilo Norata. "Anti-PCSK9 Antibodies for the Treatment of Heterozygous Familial Hypercholesterolemia: Patient Selection and Perspectives." Vasc Health Risk Manag 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..